Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.
about
Cyclophosphamide for multiple sclerosisStage-specific immune dysregulation in multiple sclerosisPharmacological Approaches to Delaying Disability Progression in Patients with Multiple SclerosisSystematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosisThe EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.Sound Lateralization Test Distinguishes Unimpaired MS Patients from Healthy Controls.Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.The use of magnetic resonance imaging in multiple sclerosis: lessons learned from clinical trials.The role of MRI in the evaluation of secondary progressive multiple sclerosis.Outcome Measures in Clinical Trials for Multiple Sclerosis.Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelinesCorticospinal tract abnormalities are associated with weakness in multiple sclerosis.Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis.Progress in determining the causes and treatment of multiple sclerosis.Using perceptive computing in multiple sclerosis - the Short Maximum Speed Walk test.Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale-29.Impact of multiple sclerosis relapses on progression diminishes with timeComposite MRI scores improve correlation with EDSS in multiple sclerosisDoes a placebo-effect exist in clinical trials on multiple sclerosis? Review of the literature.Treatment of walking impairment in multiple sclerosis with dalfampridine.Cyclophosphamide for multiple sclerosis.MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patientsClinical trials in progressive multiple sclerosis: lessons learned and future perspectivesClinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating diseaseUtility of the rio score and modified rio score in korean patients with multiple sclerosis.Changing EDSS Progression in Placebo Cohorts in Relapsing MS: A Systematic Review and Meta-Regression.T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups.Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques.Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MS.Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.Review of the clinical evidence for interferon beta 1a (Rebif) in the treatment of multiple sclerosisThe role of MRI in clinical trials of multiple sclerosis: comparison of image processing techniques.Hand function in multiple sclerosis: force coordination in manipulation tasks.Multiple measures of corticospinal excitability are associated with clinical features of multiple sclerosis.A comparative analysis of Patient-Reported Expanded Disability Status Scale tools.Predicting responders to therapies for multiple sclerosis.Clinical prognostic factors in multiple sclerosis: a natural history review.The Performance Scales disability measure for multiple sclerosis: use and sensitivity to clinically important differences.
P2860
Q24243160-5F2F3A2F-7C50-4404-9E97-CAFCF9625A36Q26852859-BF1CD905-0305-419B-B902-03358BC99E9CQ27000269-5AAB5F2F-BB11-4ABA-A17A-2EB15EFD3CD1Q27004079-0B9C77BC-DFC1-4C1C-AA56-22B0A6021EA8Q30277106-3547E312-ED91-490F-9A18-426E1E904E56Q30432891-629F7E4D-7420-4B5C-8EF7-BA828112A915Q30585635-82835E12-EF8E-46B3-9B75-AE1D5CDF0E0FQ30953733-D94DF2E3-8634-4B49-B662-49B2F3FA0EF9Q31033345-648C0409-9EB8-439D-A694-B50DFF6AEBAEQ31160866-50687238-1DC4-4728-AFD4-D84064FEA315Q33437936-4FDFD908-936C-4630-B7B5-7B039ABF6B78Q33575876-4F92B9F7-8A3C-47DD-8332-981D26470412Q33590585-AD072E43-B057-430B-9C2C-D5B796E23AEFQ33678174-BB7AE6C9-B798-4FA1-9B18-97FDFCFDAA2DQ33700629-10F3481C-D851-497E-85D0-8050380B51ECQ33887859-38D7240E-85FE-4466-B060-A6A1833C88CAQ33898204-F0CB2D46-9688-4F56-B520-721E3BF38603Q34109873-9F95665D-6E32-4DA1-B178-79EFCE7132D5Q34396068-A007F673-6F1B-4B2C-AB58-595DEF7E6406Q35018452-27654223-6F85-4F97-B9D5-95B7EBE50892Q35041827-E1EA50BE-3625-489A-A98C-9F7E735EBD76Q35148010-04CF6D5B-D09A-4F50-A06B-9ADA3874831EQ35182733-5F12C2BA-C585-4C9A-A7C8-EE6EB2875DD7Q35485603-B3229F6A-7327-427F-BEFD-D2818459F880Q35641688-3B709FA3-D39B-4EC5-8CBB-AFE2053EEEB4Q35761200-3623659A-98B6-4CF9-9C59-59780705AB8EQ35867383-0B16C275-C78E-4F81-9029-68C1AA9B0539Q36317642-7919CE1E-787B-413A-B817-E95C3A9196DAQ36318391-8866F909-F63C-41F8-A35B-239649C826A5Q36613404-82268C86-8531-4346-90F4-00E0EF79C84AQ36792204-17651AE1-B496-4DA4-B344-D4DD213C9112Q36814514-CFCF2B21-691D-44CB-A4E9-0B906A25930EQ36842201-D2FE821D-CABE-4B0B-A329-72C48D5EC4BAQ36843536-5D9C66B5-150B-4A53-A8FF-D13E24A7F9C7Q36994825-8B4B373C-0BB4-4D1B-BD1A-DF1BD3C03715Q36997289-EFC4A921-37AD-4ECF-926F-B504EC639DA6Q37241679-48EF4C2E-E149-493B-9C60-FE6BC8682118Q37606292-D330A7EA-3F06-43D1-BDA6-05B6AE986FA6Q37642594-647EACC2-2324-4FF5-AB87-6A338A696626Q37690044-33495D74-F0E9-496E-9E8F-53C13E85DED0
P2860
Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Interrater variability with th ...... an Cooperation MS Study Group.
@en
Interrater variability with the Expanded Disability Status Scale
@nl
type
label
Interrater variability with th ...... an Cooperation MS Study Group.
@en
Interrater variability with the Expanded Disability Status Scale
@nl
prefLabel
Interrater variability with th ...... an Cooperation MS Study Group.
@en
Interrater variability with the Expanded Disability Status Scale
@nl
P2093
P356
P1433
P1476
Interrater variability with th ...... an Cooperation MS Study Group.
@en
P2093
Noseworthy JH
Vandervoort MK
P304
P356
10.1212/WNL.40.6.971
P407
P577
1990-06-01T00:00:00Z